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The medico], onesthesio, ond surgicul records of 89 
consecutive pcdiutric patients who underwent em 
orthotopic hepatic transplontotion procedure o[ the 
University of Pittsburgh from Februory 1981 to Moy 
1984 were reviewed to evoluate the effect of prior 
abdominol surgery upon the morbidity and mortal-
ity of orthotopic liver transplontation in children. 
Fifty-seven children (group 1) hud hod prior obdom-
inal surgery, whereas 32 (group 2) had not. The 
group 1 subjects were younger (p < 0.001), had 
better prothrombin times (p < 0.01), and better 
platelet counts (p < 0.02) than did those in group 2. 
No difference in the duration of anesthesia or intra-
operative use of fresh frozen plasma or platelets was 
evident between the two groups. However, group 1 
potients were given more red blood cells intraopero-
tively thon were the group 2 patients (p < 0.01). The 
group 1 potients had more total postoperative infec-
tions (p < 0.05), which was due solely to 0 greater 
number of abdominal infections (p < 0.05), but 
similor toto1 hospital and intensive care unit stm's 
as did the group 2 potients. When those in group 1 
were divided into those having 0 previous Kosoi 
procedure versus those who did not, no differences 
between the two groups were oppnrent except for 
nge. Based upon these doto, we conclude that prior 
obdominnl surgery does not affect mortality, the 
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duration of hospitol or intensive care unit stn}" 
plasma or plotelet requirements, cmd total anesthe-
sia time required for orthotopic liver transplontn-
tion, but does enhance the number of red blood cell 
transfusions ond infections, particularly abdominal 
infections, in children undergoing this procedure. 
Orthotopic liver transplantation (OL Tx) is an enor-
mous surgical procedure that is hampered by the 
almost inevitable debilitation of potential recipients, 
the existence of a massive collateral circulation, and 
the presence of major coagulation abnormalities, all 
of which are problems present frequently in the 
patients in whom it is to be applied (1-4). In addi-
tion, the presence of adhesions and a variety of 
anatomic alterations due to previous abdominal op-
erations in potential recipients have been thought to 
be important complicating factors that make the 
recipient hepatectomy more difficult than it is in 
candidates without prior surgical procedures. Trans-
plant surgeons frequently state that technical prob-
lems created by prior abdominal surgery, particu-
larly portosystemic shunting procedures and biliary 
tract surgery, render OLTx a longer and more dif-
ficult procedure, with a resultant greater intraopera-
tive blood loss, more frequent postoperative compli-
cations, and an overall poorer survival than that 
which occurs in cases without preexistent surgery. 
The aim of the present study was to document 
whether or not prior major abdominal surgery has a 
deleterious influence upon the outcome and morbid-
ity associated with OLTx when applied to pediatric 
recipients. 
Abbreviation used in this paper: OL Tx, orthotopic liver trans-
plantation. 
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Table 1. Liver Disease for Which Orthotopic Liver 
Transplantation Was Applied in the Patients 
Studied 
Group 1 Group 2 
Biliary atresia 42 a,-Antitrypsin deficiency 
Chron ic cholestasis other 7 Chronic active hepatitis 
than biliary atresia Chronic cholestasis 
Chronic: active hepatitis 4 Cryptogenic cirrhosis 
<Xl-Antitrypsin deficiency 2 Wilson's Disease 
Cryptogenic cirrhosis 1 Hepatoma 
Glycogen storage disease Tyrosinemia 
Fulminant hepatitis 
Materials and Methods 
12 
5 
5 
:1 
:1 
3 
The medical, anesthesia, and surgical records of 89 
consecutive pediatric patients (18 yr or younger) who had 
an OLTx performed at the University of Pittsburgh be-
tween February 1981 and May 1984 were evaluated retro-
spectively to determine the following data: (a) the total 
anesthesia time and the total amount of intraoperative 
blood products, used as measures of the difficulty of the 
surgical procedure; (b J the number of postoperati ve infec-
tions; [c) the frequency of second surgical procedures 
during the hospital admission when the OL Tx procedure 
was performed; r d) the duration of the hospitalization after 
the OLTx and the number of days of intensive care 
requirer!; and [e) the perioperative mortality rate (from 
time of OLTx to 6 wk after performance of the procedure). 
Because not all of these patients underwent retransplan-
tation or other types of reoperation during their hospital-
izations, only the anesthesia time and intraoperative blood 
products used during the initial OL Tx procedure were 
considered. Similarly, in patients undergoing reoperations 
(n = 16), only infections that occurred during the period 
between the initial OLTx and the first reoperation were 
considered. In nonreoperated patients, the frequency of 
infection WRS determined for the entire period from the 
OL Tx until discharge. 
The patient selection methods, the surgical procedure, 
the immunosuppressive regime used, and the supportive 
care offered to these patients have each been described in 
detail previously (4-7). All of the cases included received 
comparable clinical management from the same medical 
and surgical teams, which were constant throughout the 
study period. 
For the purpose of analysis, the 89 patients included in 
the study were divided into two groups. Group 1 consisted 
of 57 patifmts who had had a major abdominal surgical 
procedure before their OL Tx and group 2 consisted of 
32 patients who had not. The prior abdominal surgical 
procedures performed in group 1 patients were porto-
enterostomy (Kasai procedure, 40 cases), exploratory 
laparotomy (9 cases), portosystemic shunt [3 cases), cho-
lecystectomy (3 cases), splenectomy (1 case), and porto-
cholecystostomy (1 case). The indications for the OLTx in 
the patient population studied arc listed in Table 1. 
Actuarial survival curves for each group of patients stur!-
ied were plotted for a period of 30 mo. 
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The results are expressed as mean ± standard error of 
the mean, Student's t-test and the K test with the Yates' 
correction when appropriate were used to analyze the 
data. A p value <0.05 was considered to be significant. 
Results 
Characteristics of the Two Patient 
Populations Studied 
The clinical and laboratory characteristics of 
the patients in groups 1 and 2 obtained immediately 
prior to OL Tx are shown in Table 2, Both groups 
were similar in terms of distribution as to sex, 
incidence of major complications of the primary 
liver disease, serum bilirubin levels, and albumin 
concentrations. The patients in groups 1 and 2 
differed significantly in terms of age (52,6 ± 4.0 and 
87.8 ± 10.6 mo, respectively; p < 0,001), prothrom-
bin time (14.3 ± 0.2 and 16.3 ± 0.7 s; P < 0.04), and 
platelet count (191 ± 17 x 103 and 129 ± 15 x 
103/mm3 ; p < 0.02). 
Operative Costs of the Procedure in the 
Patients Studied 
No statistical difference between the two 
groups was apparent for the duration of anesthesia 
(698 ± 21 min in group 1 and 643 ± 23 min in group 
2) and the intraoperative consumption of fresh fro-
zen plasma (196 ± 20 and 135 ± 23 mllkg wt) and 
platelets (13 ± 2 and 9 ± 2 mllkg wt). Patients in 
group 1, however, were given a greater amount of 
packed red blood cells during the procedure (237 ± 
29 mllkg wt) than those in group 2 (114 ± 18 mllkg 
wt; p < 0.01). 
Three patients from each group were excluded 
Table 2. Preoperative Clinical and Laboratory Data in 
the Pediatric Patients Studied" 
Group 1 Group 2 
(11 = 57) (n = 32) P 
Age (mo) 53 ± 4 88 ± 11 <0.001 
Sex (M/F) 21/36 14118 
Ascites" 24 (42%) 15 (47%) 
Gastrointestinal 26 (46%) 1:3 (41%) 
hemorrhageh 
Hepatic encepha- 6 (11%) 8 (25%) 
lopathv l ' 
Serum bilirubin 18.7 ± 1.6 18.2 ± 4.6 
(mg/dJ) 
Prothrombin time 14.3 ± 0.2 16.3 ± 0.7 <0.01 
(s) 
Serum albumin :1.5 ± 0.2 3.2 ± 0.1 
(g/dJ) 
Platelets 190,725 ± 200 128,840 ± 300 <0.02 
(No./mrn3 ) 
n Values 8re mean ± SEM. b Complication occurring before Ih'er 
transplantation. 
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from the analysis of the frequency of postoperative 
infections as they died intraoperatively (1 case in 
group 1) or within the first 72 h after the procedure (2 
cases in group 1 and 3 cases in group 2). Twenty-
seven (50%) of the remaining 54 patients in group 1 
developed a postoperative infection, whereas this 
occurred in only 8 (28%) of the 29 patients in group 
2 (p < 0.05). As shown in Table 3, this difference in 
frequency of postoperative infections also differed as 
to the location of the infection. Nineteen patients 
(35%) in group 1 developed an abdominal infection, 
whereas this complication occurred in only 3 pa-
tients (10%) in group 2 (p < 0.05). No difference 
between groups was found with respect to the pro-
portion of patients who developed a postoperative 
nonabdominal infection (13 in group 1, or 24%, and 
6 in grou p 2, or 21 %) or the number of such infec-
tions (16 and 8, respectively). The period of time 
during which the incidence of infections was con-
sidered was similar in both groups (30 ± 3 days in 
group 1 and 30 ± 4 days in group 2). 
The perioperative mortality was similar in both 
groups. Nine patients (16%) in group 1 and 7 (21')))] 
in group 2 died during the period of study. The 
duration of the hospitalization after OL Tx and the 
number of days for which the intensive care unit was 
required were similar for the children discharged 
alive in group 1 (54 ± 4 and 11 ± 3 days, respec-
tively) and those in group 2 (51 ± 5 and 8 ± 2 days) 
(Figure 1). 
Table 3. Incidence of Infections in Pediatric PUtiCilts 
Undergoing Orthotopic Liver Transplnntutioll 
Group 1 
(n = 54) 
Patients \Iith infections 27 [50%) 
Patients with ilbdomilla! 19 [35%) 
infections 
Number of abdominal in- 23 
fections 
Wound infection 9 
Peritonitis 
Intraabdominal abscess 
Hepatic abscess 
Cholangitis 
Patients with non~b­
domina! inf,,,;tions 
Numl)(,r of nUllab-
dllminal infections 
Baeterem ia 
Candidernia 
4 
4 
:3 
3 
13 (24%) 
16 
4 
3 
lIrinan- tract infection 3 
P I1lHl III eHl i a 
Otitis 
Cytomegalovirus infec-
tion 
Herpes zoster 
Herpes simplex 
2 
2 
2 
(] 
o 
Group :2 
(11 = 29) 
8 (28%) 
3 (10%) 
3 
o 
o 
6 [21'10) 
8 
3 
1 
o 
o 
o 
2 
p 
<0.05 
<0_05 
<0.05 
100 
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Figure 1. Actuarial survival curves for the three groups of pa-
tients studied. Group lA, those who had a prior Kasai 
procedure; group IB, those who had prior abdomina! 
surgery not including a Kasai procedure; and group 2, 
those without any prior surgery. No differences in 
survival are noted between the three groups for a period 
of 30 mo since the performance of the OLTx surgery. 
To determine whether patients with a pre-OLTx 
porto enterostomy (Kasai procedure) have a worse 
perioperative prognosis than do those patients with 
other types of pre-OLTx surgery, the grou p 1 patients 
were divided into two subgroups: group lA included 
40 patients who had been given a prior porto-
enterostomy, and group IB included the remaining 
17 patients who had not had a portoenterostomy but 
who had had some other type of abdominal surgery. 
As shown in Table 4 and Figure 1 no significant 
differences between groups lA and IB were found 
for pre-OLTx clinical and laboratory data, duration 
of anesthesia, amount of intraoperative blood prod-
ucts consumed, incidence and types of post-OL Tx 
infection, mortality rate, and duration of hospitaliza-
tion. The only parameter that was significantly dif-
ferent was age; children of group lA were younger 
(42.6 ± 3.5 mol than children of group IB (75.4 ± 
19.3 mo; p < 0.01). 
Discussion 
Among the many hepatobiliary disorders for 
which children are candidates for OLTx (Table 1), 
the most frequent is biliary atresia (1-4,6,7). Unfor-
tunately, both in the precyclosporine era and more 
-----------
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Table 4. Pretransplnnlution Clinical uIId Lnboratory 
Data and PosttrunsplantatioTi Cosls and Course 
of the Pediutric Patients With n PreFious 
Portoenterostomy (Group lA) us Compared 
With Those With Other Previous Types of 
Abdominal Surgery (Group lBt 
Group lA Group lB 
(n = 40) (n = 17) P 
Age (mo) 43 ± 3 75 ± 12 <0.01 
S(;X rrvlF) 15/25 6ill 
From first complaint to 
OLTx 
Ascites Hi (40'X,) 8 (47%) 
Gastrointestinal hemor- 16 (40%) 10 (59%) 
rhage 
Hepatic encephalopathy 5 (12%) I (0'%) 
Illlmediately pre-OLTx 
Serum bilirubin (lllg;dl) 18.6 ± Ui 18.a ± 4.6 
Prothrombin time (s) 14.1 ± 0.:) l-U1 ± 0.4 
Serum albumin (g/dl) 3.5 ± 0.1 3.6 ± 0.3 
Platelets (x JU!!mm 3 ) 187 ± 19 198 ± 35 
During OLTx 
Duration of anesthesia 712 ± 30 665 ± 25 
(min) 
Red blood cells transflls(;c\ 247 ± 35 ~EgB ± 35 
(llllikg) 
Fresh frozen plaslTla trans- 201 ± 24 181 ± 35 
fused (mlikg) 
Platelets transfused (mllkg) 15 ± :3 8 ± :3 
Post-OL Tx infections 
Patients with infection 1 B (45°.;,1 9 (53%) 
Patients with abdominal 13 (33°;',) 6 (35%) 
inf(;ctions 
Patients with nonab- 10 (25%1 3 (tB%J 
dominal infections 
Deaths 5 (12'){,) 4 (24%) 
For survivors 
Days in intensive care unit 10 ± 3 15 ± B 
(post-OLTx) 
Davs in hospital (post- 52 ± 4 :i9 ± 12 
ULTx) 
ULTx. orthotopic liver transplantation." Villlws arc mean ± SEM. 
recently following the widespread use of cyclo-
sporine, the long-term survival of children receiving 
liver transplants for biliary atresia has been lower 
than it has been for recipients with other indications, 
such as those with liver-based inborn metabolic 
errors [5-7). Because liver transplantation in pediat-
ric patients with biliary atresia usually is performed 
only after prior surgical attempts to restore biliary 
drainage by porto enterostomy [Kasai procedure) 
have failed, the lower survival of these patients has 
been attributed, at least in part, to the difficulties 
experienced by the surgeon during the recipient 
hepatectomy, many of which are thought to be 
callsed by the presence of adhesions and other 
anatomic alterations, which are secondary to the 
prior performance of the Kasai procedure. It also has 
been suggested that the creation of a portacaval 
- ~--K---------K---
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shunt can render subsequent OLTx more difficult 
because the residual portal vein obtained after taking 
clown the shunt, especially side-to-side shunts, may 
have a suboptimal length and sclerotic walls, which 
make the subsequent anastomosis with the donor 
portal vein more difficult (1,4). Similarly, adhesions 
due to any prior upper abdominal surgery performed 
before OLTx might also cause difficulties during the 
recipient hepatectomy and might be expected to 
extract a cost in terms of subsequent infection rates, 
mortality, and blood product consumption (1,4). 
Each of these problems has been thought to account 
for the lower survival rate of children receiving 
transplants and having had prior abdominal surgical 
procedures. 
Because the many difficulties that a surgical team 
might have during an OLTx procedure can hardly be 
analyzed in a retrospective study by nonsurgeons, 
we instead determined the duration of anesthesia 
and the volume of blood products consumed intra-
operatively in this series of consecutive pediatric 
patients undergoing OL Tx as indirect measures of 
the same. 
The duration of the anesthesia in patients with 
(group 1) and without [group 2) previous abdominal 
surgery was amazingly similar. Nonetheless, the 
volume of red blood cells consumed intraoperatively 
was twice as much in the group 1 patients as it was 
in the group 2 patients. These results suggest that, 
although the total time required to complete the 
OLTx procedure was not greater in patients who 
have had previous surgery, there was more intraop-
erative bleeding in these patients than in those 
without previous abdominal procedures. Interest-
ingly, this is true despite the fact that the patients in 
group 1 had better coagulation parameters, as indi-
cated by the lower preoperative prothrombin time 
and a greater platelet count, than did the patients in 
group 2. Presumably, because fresh frozen plasma 
and platelets were transfused only to correct abnor-
malities detected by repetitive monitoring of the 
thromboelastogram, similar volumes of fresh frozen 
plasma and platelets were administered to the two 
groups studied. 
Despite similar operative times, the incidence of 
postoperative abdominal infections was more than 
three times greater in the patients who had had 
previous abdominal surgery [group 1, 35%) than it 
was in the patients who had not had such prior 
surgery (group 2, 10%). Moreover, not only were the 
measures of severity of the preexistent liver disease 
quite similar between the two groups (Table 2], so 
also were the postoperative immunosuppressive 
regimens (data not given) and the frequency of 
nonabdominal infections (24% and 21 (Yo, respec-
tively). Thus the greater incidence of abdominal 
April 1986 
infections seen in the group 1 patients cannot be 
related to a reduced defense against infections, but 
rather must be ascribed to the fact of having had a 
previous abdominal operation. 
It is of some interest that the patients in group 1 
were younger than were the patients in_ group 2 
(Table 2). Because patients in both groups had a 
similar frequency of nonabdominal infections, the 
age of the patient at the time of surgery presumably 
did account for the greater frequency of intraabdom-
inal infections seen in the group 1 subjects. More-
over, as the patients in group lA, who had had a 
prior Kasai procedure, were also younger than those 
in group lB and the incidence of abdominal and 
nonabdominal infections was similar in both sub-
groups, age would not appear to be an important 
factor determining the increased risk of intraabdom-
inal infection in the group 1 patients. Similarly, it is 
most unlikely that age played any role in the higher 
intraoperative consumption of blood cells observed 
in the group 1 patients. Nonetheless, it should be 
noted that in patients with advanced liver disease. 
age and size are not interrelated as they are in the 
normal population, as children with such disease are 
disproportionately small due to their illness and its 
associated problems, such as malabsorption and 
inanition. 
Most interesting is the fact that the patients with 
pretransplant abdominal surgery (group 1) did not 
have a greater mortality rate than did the patients 
without any pretransplant abdominal surgery (group 
2). These results indicate that, in spite of the greater 
intraoperative bleeding and frequency of postopera-
tive abdominal infections, pediatric patients under-
going OLTx after previous abdominal operations 
have a similar overall outcome as compared with 
those without such previous abdominal surgery. 
Thus it can be concluded that the existence of a 
previous abdominal surgical procedure has to be 
considered as being only a minor contraindication 
for OL Tx-one that increases the morbidity but not 
I'R.IOR. SURGERY A'-:D PEIlIATRIC OLTx HC,7 
the mortality associated with the procedure in pedi-
atric recipients. Additionally, because the intraoper-
ative and postoperative courses of transplanted chil-
dren with biliary atresia and prior portoenterostomy 
did not differ from those of children with other 
hepatobiliary diseases and other types of abdominal 
surgery, it can be concluded that the existence of a 
portoenterostomy (Kasai procedure 1 does not put a 
child at a greater risk of a postoperative complica-
tion, prolonged hospitalizatioIl, and death than does 
the existence of any other types of major abdominal 
surgery in a child undergoing such surgery. More-
over, because children with biliary atresia with or 
without a prior Kasai operatioIl are smaller ane! 
younger than children with other liver diseases 
treated with OL Tx but have similar survival charac-
teristics, size of the pediatric OL Tx recipient, al-
though a technical problem for the operating sur-
geon, does not appear to adversely affect the 
morbidity and mortality associated with the proce-
dure. 
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